Global Vitiligo Therapeutics Market to Reach $2 Billion by 2027
Amid the COVID-19 crisis, the global market for Vitiligo Therapeutics estimated at US$1.5 Billion in the year 2020, is projected to reach a revised size of US$2 Billion by 2027, growing at a CAGR of 3.8% over the analysis period 2020-2027. Topical, one of the segments analyzed in the report, is projected to record a 3.5% CAGR and reach US$974.9 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Oral segment is readjusted to a revised 4.2% CAGR for the next 7-year period.
The U.S. Market is Estimated at $448.2 Million, While China is Forecast to Grow at 3.6% CAGR
The Vitiligo Therapeutics market in the U.S. is estimated at US$448.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$351.8 Million by the year 2027 trailing a CAGR of 3.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.4% and 3.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.
Other Segments Segment to Record 3.7% CAGR
In the global Other Segments segment, USA, Canada, Japan, China and Europe will drive the 3.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$151.4 Million in the year 2020 will reach a projected size of US$196.4 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$220.7 Million by the year 2027.
Select Competitors (Total 38 Featured):
Amid the COVID-19 crisis, the global market for Vitiligo Therapeutics estimated at US$1.5 Billion in the year 2020, is projected to reach a revised size of US$2 Billion by 2027, growing at a CAGR of 3.8% over the analysis period 2020-2027. Topical, one of the segments analyzed in the report, is projected to record a 3.5% CAGR and reach US$974.9 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Oral segment is readjusted to a revised 4.2% CAGR for the next 7-year period.
The U.S. Market is Estimated at $448.2 Million, While China is Forecast to Grow at 3.6% CAGR
The Vitiligo Therapeutics market in the U.S. is estimated at US$448.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$351.8 Million by the year 2027 trailing a CAGR of 3.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.4% and 3.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.
Other Segments Segment to Record 3.7% CAGR
In the global Other Segments segment, USA, Canada, Japan, China and Europe will drive the 3.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$151.4 Million in the year 2020 will reach a projected size of US$196.4 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$220.7 Million by the year 2027.
Select Competitors (Total 38 Featured):
- Aclaris Therapeutics
- Astellas Pharma
- Bausch Health
- Baxter
- Bristol-Myers Squibb
- Celgene
- Clinuvel Pharmaceuticals
- Mallinckrodt
- Puneet Laboratories
Frequently Asked Questions about the Global Market for Vitiligo Therapeutics
What is the estimated value of the Global Market for Vitiligo Therapeutics?
What is the growth rate of the Global Market for Vitiligo Therapeutics?
What is the forecasted size of the Global Market for Vitiligo Therapeutics?
| Report Attribute | Details |
|---|---|
| No. of Pages | 125 |
| Published | April 2021 |
| Forecast Period | 2020 - 2027 |
| Estimated Market Value ( USD ) in 2020 | $ 1.5 Billion |
| Forecasted Market Value ( USD ) by 2027 | $ 2 Billion |
| Compound Annual Growth Rate | 4.2% |
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
